Celecoxib as a Valuable Adjuvant in Cutaneous Melanoma Treated with Trametinib.
Diana Valentina TudorIoana BâldeaElena Diana OlteanuEva Fischer-FodorVirag PiroskaMihai LupuTudor CăliniciRoxana Maria DeceaGabriela Adriana FilipPublished in: International journal of molecular sciences (2021)
Low concentrations of celecoxib (IC50 in nM range) sufficed to exert antineoplastic capabilities and enhanced the therapeutic response of metastatic melanoma treated with trametinib.
Keyphrases